Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.0
Scopus CiteScore – 3.7 (CiteScore Tracker 3.3)
Index Copernicus  – 161.11; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2021, vol. 30, nr 4, April, p. 387–394

doi: 10.17219/acem/131962

Publication type: original article

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Cite as:


Duan L-S, Liu Y, Li Z-Z, et al. The effect of different storage times on the oxygen-carrying capacity of the exosomes of red blood cells. Adv Clin Exp Med. 2021;30(4):387–394. doi:10.17219/acem/131962

The effect of different storage times on the oxygen-carrying capacity of the exosomes of red blood cells

Li-Shuang Duan1,A,B,C,D,F, Yang Liu2,A,B,C,D,F, Zhen-Zhou Li1,B,C,E,F, Huan Wang1,B,C,F, Xiao-Fang Zhou1,B,C,F, Xiao-Xiao Wang1,B,C,F, Zi-Wei Zhang1,C,F, Yi-Qun Kang1,C,F, Yong-Jun Su3,C,F, Jian-Rong Guo1,2,C,E,F

1 Department of Anesthesiology, Shanghai Gongli Hospital, The Second Military Medical University, China

2 Ningxia Medical University, Gongli Hospital of Shanghai Pudong New Area Training Base, China

3 Department of Anesthesiology, Fujian Provincial Hospital South Branch, Fuzhou, China

Abstract

Background. After storing blood for a period of time, the structure and properties of the red blood cells (RBC) will change, which results in a decrease in the oxygen-carrying capacity, and further has a certain impact on their exosomes.

Objectives. Effective oxygen uptake (Q), P50, 2,3-DPG, and Na+-K+-ATP of RBC after different storage times were detected. Electron microscopy was used to observe the morphology of RBC and the characteristics of secreting exosomes. Western blot was used to detect the expression of phenotypes CD63 and CD81 of exosomes, and the expression of mitochondrial riboprotein MRPS35 of exosomes was also detected to explore the mechanism of decreased function of RBC with the extension of preservation time.

Materials and methods. After the RBC suspension was prepared, the effective oxygen-carrying capacity (Q) and P50, as well as 2,3-DPG and Na+-K+-ATP were prepared. This was followed by morphology observation of erythrocyte exosomes using transmission electron microscope (TEM), and by western blot analysis of exosome phenotypes CD63 and CD81.

Results. Erythrocytes secrete exosomes, which results in abnormal expression of related proteins in mitochondria. This leads to increased ROS production, mitochondrial apoptosis and, finally, changes in or damage to erythrocytes.

Conclusions. Changes in the rheological properties and oxygen-carrying functions of erythrocytes during preservation are all observable manifestations, underlying which lie mechanisms of damage at the molecular level of erythrocytes. Erythrocytes secrete exosomes, which results in abnormal expression of related proteins in mitochondria, increasing ROS production, mitochondrial apoptosis and, finally, changes or damage to erythrocytes.

Key words: exosomes, red blood cells, storage time, oxygen-carrying capacity

Background

Blood is a fluid tissue composed of blood cells and plasma. Its main physiological functions include transporting oxygen, nutrients and metabolites for tissues and organs of the body. The body takes the oxygen needed for metabolism from the atmosphere through breathing and expels carbon dioxide produced by metabolism. In the human body, the respiratory process includes 3 processes that are conducted at the same time, namely, external respiration, transportation of gas in blood and internal respiration, while red blood cells (RBC) are the main means of gas transportation.1 The amount of oxygen physically dissolved in the blood only accounts for 1.5% of the total oxygen and 98.5% of oxygen is transported by binding to the hemoglobin of RBC.2 In a sense, RBC are able to distinguish active and inactive cells that take part in metabolism and release oxygen to active cells.

In modern medicine, it is very common therapeutic practice to transfer blood or blood components to patients, which can increase blood volume and plasma protein, improve circulation, change blood composition, and improve blood oxygen-carrying capacity. Due to the widespread using of blood transfusion in clinical practice, the function of blood preservation has been reconsidered. The structure and properties of RBC will change and their oxygen-carrying capacity will decrease after preservation for a period of time. However, the influence of changes in oxygen-carrying capacity on their erythrocyte exosomes has not been reported.

Objectives

Our research aimed to detect some relative parameters of oxygen-carrying activity and exosomes of erythrocyte storing in different storage time to explore the mechanism of erythrocyte function decline.

Materials and methods

Materials

Flow meter (Changzhou Chengfeng Flow Meter Company, Changzhou, China); pressure gauge (Yangquan Precision Instrument Factory, China); Cy-3 digital oxygen analyzer (Shanghai Huaguang Instrument Factory, Shanghai, China); BC-2800 blood count instrument (Mindray Medical International, Shenzen, China); 37°C constant temperature water bath (GSY-II; Beijing Medical Equipment Factory, Beijing, China); low speed M109077 automatic centrifuge (Zhongxi, Shanghai, China); 200 L and 1000 L samplers (Eppendorf, Hamburg, Germany); AB fresh/frozen plasma and defoaming agent were donated from blood bank; 2,3-DPG detection kit (Wuhan Huamei Biotechnology Company, Wuhan, China); Na+-K+-ATPase assay kit (Nanjing Jiancheng Biological Company, Nanjing, China); rabbit anti-human CD63 antibody, rabbit anti-human CD81 antibody (System Biosciences, Palo Alto, USA); H7600 transmission electron microscope (TEM) (Hitachi, Tokyo, Japan); and exosome extraction kit (Sigma-Aldrich, St. Louis, USA).

Preparation of RBC suspension

A total of 400 mL whole blood were collected from 5 healthy blood donors and all blood samples were examined to confirm that they accord with the national blood and component blood quality requirements.3 When they passed the examination and conformed to the operation procedures of blood station technical operation regulations (2012 edition), the blood samples were prepared into suspended RBC.4 Suspended RBC were divided into 5 empty bags using sterile bonder, and named 1 day group, 7 day group, 14 day group, 21 day group, and 28 day group. Q, P50, 2,3-DPG and Na+-K+-ATP in suspension of RBC and whole blood were observed. This research has been authorized for ethical review by hospital committees, and all volunteers agree to sign the informed consent.

Measurement of effective oxygen-carrying capacity (Q) and P50

The blood samples were centrifuged with 3696 × g/min at 4°C for 10 min after conventional anticoagulant treatment. Then plasma was removed and CPDA-1 erythrocyte preservation fluid was added to prepare suspended RBC. Suspended RBC coming from the same patient were divided into 5 copies and restored at 4°C. The blood samples were tested at 1, 7, 14, 21, and 28 days. Arterial oxygen partial pressure was simulated under the following test conditions: O2 = 16 mL/min, CO2 = 3 mL/min, N2 = 120 mL/min, flow rate: 100 mL/min, 37°C to sample inflatable for 9 min. Finally, 1 mL of the sample was extracted for blood gas analysis. The charging conditions were adjusted to O2 = 6 mL/min, CO2 = 3 mL/min, N2 = 160 mL/min, and the flow rate was 100 mL/min. Samples were inflated for 6 min at 37°C after being balaced for 10 min. Finally, 1 mL of the sample was also extracted for sexual blood gas analysis. According to the calculation formula of effective oxygen-carrying capacity of erythrocytes, Q = 20 × (S1-S2). When the oxygen partial pressure rose to 100 mm Hg (pulmonary arterial partial oxygen pressure) and stabilized, the oxygen saturation of hemoglobin in the solution was measured and recorded as S1. When the oxygen partial pressure of mixed gas was 40 mm Hg (oxygen partial pressure of pulmonary venous blood), the oxygen saturation of hemoglobin was measured and recorded as S2. P50 value was calculated according to the blood gas analysis results when the oxygen partial pressure reached 100 mm Hg.5

Measurement of 2,3-DPG and Na+-K+-ATP

Suspended erythrocytes obtained from 1 patient were divided into 5 portions and measured at 1, 7, 14, 21, and 28 days according to the 2,3-DPG and Na+-K+-ATP kit instructions.6

Morphology observation of erythrocyte

Morphology of erythrocytes was characterized on H7600
TEM at 0, 7, 14, 21, and 28 days after the storage of erythro­
cytes.

Observation of erythrocyte exosomes

Extraction of exosomes

RBC solution (1 mL) was put into a centrifuge tube and 7.5 mL of phosphae-buffered saline (PBS) was added. Organelles were removed after centrifuging for 30 min at 10,000 × g at 4°C. Then, supernatant was centrifuged and concentrated by using a 100 kDa Millipore ultrafiltration centrifugal pipe (Merck Millipore, Burlington, USA) at 1000 × g at 4°C for 30 min. The concentrate was filtered with 0.22 μm according to operating instructions for tissue culture medium and precipitation liquid was added into the supernatant in a proportion of 5 : 1 at 4°C overnight for precipitation (>12 h). Exosome suspension was obtained after centrifuging at 1000 × g at 4°C for 30 min and stored at –80°C.7

Morphology observation of exosome with TEM

One drop of erythrocyte exosomes suspended in PBS was taken and dropped onto the copper sample carrier network with a diameter of 2 nm. After staying at room temperature for 2 min, the edge liquid was gently absorbed with filter paper. Then, 3% phosphotungstic acid solution (pH = 6.8) was retained at room temperature for 5 min. The morphology of exosomes was observed using TEM.

Western blot analysis of exosome phenotypes CD63 and CD81

Extraction of exosome protein

The PBS resuspended exosomes were mixed with RIPA at a ratio of 1:1 according to an appropriate volume, and then the exosomes were allowed to rest on ice to shake violently for 1 min. This procedure was repeated 5 times to fully crack the exosomes. The concentration of exosome protein was determined using BCA method and a third volume of 4 × SDS buffer was added to samples, which were boiled at 100°C for 5 min and preserved at –80°C.

Western blot analysis of protein CD63 and CD81

SDS-PAGE was prepared with a concentration of 10–12%, and the sample was loaded at a total protein mass of 50 μg per well. SDS-PAGE was performed at a voltage of 80 V and 100 V for the laminated and separated gels, respectively. The protein was transferred to polyvinylidene fluoride (PVDF) membrane after electrophoresis under 350 mA constant current condition for 2 h. The PVDF membrane was incubated shaking for 1 h in 5% skimmed milk, then rabbit anti-human CD81 antibody (1 : 500) or CD63 antibody (1 : 500) were added to incubate at 4°C overnight. The film was washed 3 times with 1 × Tris-buffered saline with Tween (TBST). Horseradish peroxidase (HRP)-labeled rabbit anti-sheep (1 : 1500) was added to incubate at 37°C for 1 h. The film was washed 5 times with 1 × TBST and exposed to analysis.8

Western blot

Western blot was used to detect MRPS35 expression. A total of 40 μg protein were extracted from each cell, analyzed using 10% SDS-PAGE and transferred to nitrocellulose membrane. With sealing fluid containing 5% skimmed milk powder, the membrane was incubated at 37°C for 1 h, then MRPS35 antibodies (1 : 500) were added to incubate at 4°C overnight. After enhanced chemiluminescence (ECL) developing, the gray value was analyzed using the analysis system of electrophoresis gel imaging.

Statistical analysis

All data were processed using the SPSS v. 19.0 statistical software (IBM Corp., Armonk, USA) and expressed as mean ± standard deviation (SD). A paired t-test was performed to compare the 2 groups. Statistical significance was defined as p < 0.05.

Results and discussion

Effective oxygen-carrying capacity and P50

Effective oxygen-carrying capacity (Q) of whole blood and RBC suspensions had declined with the enhancement of storage time, as shown in Table 1. Figure 1A shows that Q decreased sharply in the first 14 days and gently after ­further 14 days. The Q of suspension RBC decreased by 54.4% at 14 days and 62.7% at 28 days, while that of whole blood decreased by 39.1% at 14 days and 52.1% at 28 days. P50 of RBC decreased gradually as the storage days increased as shown in Figure 1B. It shows that the P50 of suspension RBC decreased by 11.6% at 14 days and 25.1% at 28 days. Whole blood P50 was reduced by 16.1% at 14 days and 28.6% at 28 days.

Hamasaki et al.9 first used the method of measuring Q to evaluate the change of erythrocyte oxygen-carrying capacity. They found that Q had a linear relationship with storing time and gradually declined with the enhancement of storage time. The lower the P50, the greater the affinity between RBC and oxygen, and the greater the ability to bind with oxygen, which is not conducive to oxygen release.10 It can be demonstrated from the results of decreased Q and P50 that the ability of releasing oxygen of RBC was also decreased.

2,3-DPG and Na+-K+-ATP

At the first 14 days, the concentration of 2,3-DPG in RBC declined sharply and then leveled off after 14 days. The data showed that it decreased by 63.0% at the 7th storage day and by 91.7% at the 14th storage day (Table 2). The concentration of 2,3-DPG in whole blood gradually decreased with the increase of storage days, which was not as dramatic as that of RBC (Figure 2A). The concentration of Na+-K+-ATP in erythrocytes decreased gently in the first 7 days, and then decreased sharply from 7 to 14 days. The concentration of Na+-K+-ATP decreased by 53.8% in 7 days after storage and 69.5% in 14 days after storage. The concentration of Na+-K+-ATP in the whole blood decreased by 41.2% after 7 days and by 63.3% after 14 days (Figure 2B).

2,3-DPG is the unique glycolytic intermediate of RBC, which can reduce the affinity between hemoglobin and oxygen, and is one of the important factors to regulate the physiological function of oxygen transport in the body. In some physiological and pathological conditions, such as mountaineering, plateau, anemia and congenital heart disease, the level of 2,3-DPG in RBC is significantly increased to compensate for the ability of hemoglobin to release oxygen for tissue metabolism. On the contrary, in some pathological conditions, the decreased content of 2,3-DPG is not conducive for utilization of oxygen in tissue cells, such as acidosis or shock.11, 12 The lower content of 2,3-DPG makes it difficult to release oxygen, which indicated that the oxygen-carrying capacity of RBC is decreased and the physiological function of RBC is variable.

Red blood cells regulate cell volume mainly by regulating intracellular Na+ and K+ content through membrane Na+-K+-ATP, and maintaining this function requires about 30% of RBC’s ATP production.13, 14 Na+-K+-ATP changes its conformation through phosphorylation and dephosphorylation, which lead to changes in its affinity with Na+ and K+. The role of “sodium-potassium pump” is to maintain cell permeability and cell volume.15, 16 Under normal physiological conditions, Na+ (1.0–2.0 mmol/L) in RBC was slightly higher than K+ (0.8–1.5 mmol/L) when it was passively transported into the cytoplasm. Both the increase of Na+ and the decrease of K+ in RBC can activate Na+-K+-ATP. Na+-K+-ATP is involved in the active transmembrane transport of Na+ and K+ inside and outside the cell to maintain the balance of ions.17 Na+-K+-ATP also plays an important role in maintaining the normal morphology of cells, and the survival of RBC depends on the energy provided by ATP.18 However, decreased activity of Na+-K+-ATP will reduce the release of ATP energy and affect the normal metabolism of RBC.

Observation of erythrocyte morphology

The first 14 days of storage were characterized by cell morphology, defined as double concave disc, thick edge, round or oval, nucleate-free, dense, and with a diameter of 15–25 μm. The number of cells decreased after 14 days, and the TME images of RBC at storage days 21 and 28 were sparse and irregular. Therefore, the storage time has a certain effect on the morphology of erythrocytes, which can further cause the decline of erythrocyte function and increased damage (Figure 3).

Observation of exosomes in RBC

As it can be seen from the electron microscope images, the particle size of the material ranges from 30 to 100 nm and the morphology is vesicular. After 7 days of storage, in the electron micrograph, exosomes appeared as black spots as shown in Figure 4. The black spots gradually increased after 14 days and increased more by the 14th and 21st days. These 2 time points showed the most number and clearest exosome morphology.

Previous studies have confirmed that the vesicles in vivo are divided into 3 categories: 1) vesicles released by apoptosis with micron-scale particle sizes; 2) vesicles formed by budding of the cell membrane, with particle sizes of several hundred nanometers; 3) exosomes, with micron-scale particle size below 100 nm. Therefore, we believed that the vesicles in TEM images were exosomes.

Western blot analysis of protein CD63 and CD81

Western blot analysis probing for 2 exosome marker proteins, CD81 and CD63, was performed. As shown in Figure 5, both CD63 and CD81 proteins were absent or hardly detectable in the isolated vesicles at a storage time of 7 days, but the expression of CD63 and CD81 proteins could be clearly detected at a storage time of 14 days. Western blot analysis probing for 2 exosome marker proteins, CD81, CD63, and MPRS35 were performed, as shown in Figure 5 and Figure 6. The increased expression of CD81/CD63 protein indicates that exosomes secreted were increased by RBC.

Minetti et al.19 discovered a membranous vesicle from the culture medium of reticulocyte. These vesicles were exosomes, and many kinds of cells could secrete exosomes under normal and pathological conditions. The exosomes were discoid vesicles with a diameter of 40–100 nm, which were mainly derived from polyvesicles formed by intracellular lysosomal microparticles, and these were released into the extracellular matrix after the fusion of the extracellular membrane of polyvesicles with the cell membrane. Exosomes were identified as nano-level vesicles secreted by living cells, and included proteins, nucleic acids, metabolites and other components from the mother cells. They not only carried the information of the mother cells, but also directly or indirectly regulated the functions and phenotypes of the receiving cells.20 Exosomes played an important role in immunopathology, such as antigen presentation, tumor growth and migration, tissue damage repair etc. Exosomes played an irreplaceable role in signal transduction in vivo, and also played an extremely important role in numerous physiological and pathological processes, including cardiovascular diseases,21 nervous system diseases,22, 23 and therapy.24, 25 Meanwhile, exosomes secreted by different cells had different components and functions, which could be used as biomarkers for disease diagnosis.

Western blot analysis
of exosome protein MRPS35 expression

The expression of MRPS35 increased from the 7th day to the 21st day after storage, and the relative expression of MRPS35 was significantly different from that at the storage time of day 14 and day 21. However, the expression of MRPS35 in erythrocyte mitochondria was significantly reduced at the storage time of 28 days. Abnormal expression of MRPS35 protein can induce apoptosis of normal cells. Relevant studies have proved that MRPS35 is a key protein which affects mitochondrial function, and plays a very important role in the occurrence of apoptosis. Mitochondria are an important organelle in eukaryotic cells. They can provide ATP which are the main source of energy and heat for life by oxidative phosphorylation of the electron transport chain in their inner membrane. In addition, mitochondria also played a key role in the process of apoptosis regulation. The abnormal expression of MRPS35 can make the mitochondrial electron transport barriers, and induce the production of free radicals increases, which leads to mitochondrial structure and function damage and the decrease of membrane potential, further to activate mitochondrial mediated apoptosis pathway and accelerate the apoptosis of RBC.

Conclusions

Changes in the rheological properties and oxygen-carrying functions of erythrocytes during the preservation process are manifestations, which lie in the mechanisms of damage at the molecular level of erythrocytes.

Tables


Table 1. Changes of RBC oxygen-carrying capacity at different storage time

Group

(d)

1

7

14

21

28

Whole blood

Q [mL]

5.70 ±0.08

4.80 ±0.08

3.47 ±0.12

2.90 ±0.08

2.73 ±0.12

P50 [mm Hg]

27.3 ±0.6

24.6 ±0.4

22.9 ±0.3

20.8 ±0.9

19.5 ±0.5

Suspension RBC

Q [mL]

5.90 ±0.08

3.37 ±0.12

2.67 ±0.12

2.37 ±0.26

2.20 ±0.16

P50 [mm Hg]

25.1 ±0.2

23.6 ±0.4

22.2 ±0.2

20.9 ±0.2

18.8 ±0.3

Table 2. Changes of erythrocyte oxygen-carrying capacity at different storage time

(d)

Group

1

7

14

21

28

2,3-DPG [μmol/mL]

suspension RBC

4.14 ±0.07

1.53 ±0.03

0.34 ±0.02

0.25 ±0.02

0.26 ±0.01

2,3-DPG [μmol/mL]

whole blood

4.3 ±0.07

3.57 ±0.11

1.89 ±0.10

1.43 ±0.18

0.63 ±0.10

Na+-K+-ATP [μmol PI.gHb–1hour–1]

suspension RBC

6.79 ±0.23

6.17 ±0.04

3.14 ±0.06

2.47 ±0.08

2.07 ±0.03

Na+-K+-ATP [μmol PI.gHb–1hour–1]

whole blood

7.18 ±0.12

6.39 ±0.04

4.22 ±0.13

2.93 ±0.07

2.63 ±0.07

Figures


Fig. 1. Changes in oxygen-carrying capacity in whole blood and suspension RBC
A – effective oxygen-carrying volume of whole blood and suspension RBC; B – P50 of whole blood and suspension RBC.
Fig. 2. Changes in 2,3-DPG, Na+-K+-ATP in RBC and whole blood in different storage times
A – the concentration of 2,3-DPG; B – the content of Na+-K+-ATP.
Fig. 3. Changes in erythrocyte morphology after different storage times. The scale bar was 100 nm
Fig. 4. TEM imaging of exosome in RBC in different storage times. Exosome was marked with arrow. The scale bar was 100 nm
Fig. 5. Western blot analysis of expression levels of exosome-associated proteins CD63 and CD81
Fig. 6. Protein level of MRPS35 in RBC after different storage times, determined with western blotting (mean ±SD, n = 3. **p < 0.01 compared to 7 days group)

References (27)

  1. Yoshida T, Prudent M, D’Alessandro A. Red blood cell storage lesion: Causes and potential clinical consequences. Blood Transfus. 2019;17(1):27–52. doi:10.2450/2019.0217-18
  2. Shah A, Brunskill SJ, Desborough MJ, Doree C, Trivella M, Stanworth SJ. Transfusion of red blood cells stored for shorter versus longer duration for all conditions. Cochrane Database Syst Rev. 2018;12(12):Cd010801. doi:10.1002/14651858.CD010801.pub3
  3. Lagerberg JW, Salado-Jimena JA, Löf H, et al. Evaluation of the quality of blood components obtained after automated separation of whole blood by a new multiunit processor. Transfusion. 2013;53(8):1784–1807. doi:10.1111/trf.12010
  4. Pasqualetti D, Ghirardini A, Arista MC, et al. Blood component fractionation: Manual versus automatic procedures. Transfus Apher Sci. 2004;30(1):23–28. doi:10.1016/j.transci.2003.07.002
  5. Timmerman LA, Holton T, Yuneva M, et al. Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell. 2013;24(4):450–465. doi:10.1016/j.ccr.2013.08.020
  6. Aktaran Bala D, Ozcan M. The effects of freezing on long-term storage of canine erythrocytes. Pol J Vet Sci. 2016;19:401–406. doi:10.1515/pjvs-2016-0050
  7. Mao JH, Liang ZF, Tian YQ, et al. Effects of different states of p53 on the exosomes secreted by mouse bone marrow mesenchymal stem cells. Journal of Jiangsu University. 2017;27:103–106. http://en.cnki.com.cn/Article_en/CJFDTotal-ZJYZ201702003.htm
  8. Klymiuk MC, Balz N, Elashry MI, Heimann M, Wenisch S, Arnhold S. Exosomes isolation and identification from equine mesenchymal stem cells. BMC Vet Res. 2019; 15(1):42–49. doi:10.1186/s12917-019-1789-9
  9. Hamasaki N, Yamamoto M. Red blood cell function and blood storage. Vox Sang. 2000;79(4):191–197. doi:10.1159/000056729
  10. Dinkla S, Peppelman M, van der Raadt J, Atsma F. Phosphatidylserine exposure on stored red blood cells as a parameter for donor-dependent variation in product quality. Blood Transfus. 2014;12(2):204–209. doi:10.2450/2013.0106-13
  11. Xiong Y, Xiong Y, Wang Y, et al. Exhaustive-exercise-induced oxidative stress alteration of erythrocyte oxygen release capacity. Can J Physiol Pharmacol. 2018;96(9):953–962. doi:10.1139/cjpp-2017-0691
  12. Luisada-Opper AV. Colorimetric determination of 2,3-diphosphoglycerate in whole blood. Clin Chem. 2020;19(1):118–120. PMID:4683355
  13. Cetinkaya CD, Gurbilek M, Koc M. Evaluation of the relationship of erythrocyte membrane Na+/K+-ATPase enzyme activity and tumor response to chemoradiotherapy in patients diagnosed with locally advanced nonsmall cell lung cancer and glioblastoma multiforme. J Cancer Res Ther. 2018;14(9): 450–457. doi:10.4103/jcrt.JCRT_675_15
  14. Deryugina AV, Boyarinov GA, Simutis IS, Nikosiskiy VO. Correction of metabolic indicators of erythrocytes and myocardium structure with ozonized red blood-cell mass. Cell Tissue Biol. 2018;12(3):207–212. doi:10.1134/S1990519X18030033
  15. Mackay A, Davies DL, Horton PW. Is thallium-201 of use in the measurement of total exchangeable potassium in man? Eur J Clin Invest. 2008;8(4):261–262. https://doi.org/10.1111/j.1365-2362.1978.tb00863.x
  16. Patrick J. The relationship between intracellular and extracellular potassium in normal and malnourished subjects as studied in leukocytes. Pediatr Res. 1978;12(7):767–770. doi:10.1203/00006450-197807000-00005
  17. Yi J, Zhang XQ, Mu SJ. Effects of high dose rate and low dose radiation on human erythrocyte atpase. Clinical Blood Transfusion and Examination. 2009;11:25–26. doi:10.1016/j.ijrobp.2009.07.1273
  18. Dai XF, Huang SF; Clinical Laboratory Department. Relevant research on potassium in plasma and erythrocyte,blood pH,and enzymatic activity of Na+-K+-ATP in patients with hypokalaemic periodic paralysis. China Modern Medicine. 2013;31:29–31.
  19. Minetti G, Achilli C, Perotti C, Ciana A. Continuous change in membrane and membrane-skeleton organization during development from proerythroblast to senescent red blood cell. Front Physiol. 2018;9:286. doi:10.3389/fphys.2018.00286
  20. Li D, Ren H, Liu C, Wang F, Zhang L. A study on the invention and experiments of a new type of blood preservation liquid. Chin J Blood Transfus. 2013;09:841–842. doi:10.1016/j.ijpe.2014.12.013
  21. Ong SG, Lee WH, Huang M, et al. Cross talk of combined gene and cell therapy in ischemic heart disease: Role of exosomal micro RNA transfer. Circulation. 2014;130(11 Suppl 1):S60–69. doi:10.1161/CIRCULATIONAHA.113.007917
  22. Haney MJ, Klyachko NL, Zhao Y, et al. Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release. 2015;207:18–30. doi:10.1016/j.jconrel.2015.03.033
  23. Yuyama K, Sun H, Mitsutake S, Igarashi Y. Sphingolipid-modulated exosome secretion promotes clearance of amyloid-beta by microglia. J Biol Chem. 2012;287(14):10977–10989. doi:10.1074/jbc.M111.324616
  24. Zhang L, Zhang S, Yao J, et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature. 2015;527(7576):100–104. doi:10.1038/nature15376
  25. Yuan FL, Wu QY, Miao ZN, et al. Osteoclast-derived extracellular vesicles: Novel regulators of osteoclastogenesis and osteoclast-osteoblasts communication in bone remodeling. Front Physiol. 2018;30:1–6. doi:10.3389/fphys.2018.00628
  26. Bardyn M, Rappaz B, Jaferzadeh K, et al. Red blood cells ageing markers: A multi-parametric analysis. Blood Transfus. 2017;15(3):239–248. doi:10.2450/2017.0318-16
  27. Kim JK, Park J-H, Han S-B, Cho IY, Jang K-M. Allogeneic blood transfusion is a significant risk factor for surgical-site infection following total hip and knee arthroplasty: A meta-analysis. J Arthroplasty. 2017;32(1):320–325. doi:10.1016/j.arth.2016.08.026